[Bronchial asthma: factors which contribute to "intractable asthma" and approach to new treatments, from the standpoint of the bronchial pathophysiology].
Satake
T
T
D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000485:Allergens / Q000276:immunology; D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000276:immunology; D001985:Bronchial Provocation Tests; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002395:Catecholamines / Q000097:blood; D000242:Cyclic AMP / Q000097:blood; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D008297:Male; D008875:Middle Aged; D011943:Receptors, Adrenergic, beta / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D000485:Allergens; D001993:Bronchodilator Agents; D002395:Catecholamines; D011943:Receptors, Adrenergic, beta; D000242:Cyclic AMP